AN UNBIASED VIEW OF LDN-27219 AS A CANCER DRUG CANDIDATE

Consensus sequence for tTG crosslinking substrates. Alignment of all glutamine-donor crosslinking substrates described while in the Transdab database demonstrates that apart from glutamine (Q at place 0), There is certainly tiny to no favoritism for different residues at up to 5 positions in advance of or following the glutamine residue to get cros